The FDA clearance is a significant regulatory milestone for Intuitive Surgical, allowing the company to market and sell its da Vinci 5 surgical system in the United States. This approval likely enhances the company's competitive position in the surgical systems market and is expected to positively impact its stock price in the short term due to increased investor confidence in the company's growth prospects.